Inhaled pitavastatin reduces airway hyperresponsiveness and air trapping: implications for the treatment of asthma and COPD - Amsterdam 2025

The bigger picture: comorbidities and cross-treatment effects in airway disease

Chair(s): Konstantinos Kostikas, Laura Bergantini

Session type: Poster session

Inhaled pitavastatin reduces airway hyperresponsiveness and air trapping: implications for the treatment of asthma and COPD

Yuto Yasuda

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Comparative effectiveness of angiotensin receptor-neprilysin inhibitors versus renin-angiotensin system inhibitors in patients with comorbid heart failure and chronic obstructive pulmonary disease.

Kuang-ming Liao

Poster

Abstract

Reduced mortality and cardiopulmonary risk for patients with COPD and asthma when initiating single inhaler triple therapy compared to multiple inhaler triple therapy (MITT): MAZI Asthma Study

Claus Vogelmeier

Poster

Abstract

Prevalence of ischemic heart disease in GOLD subgroups COPD patients

Roberta Cianci

Poster

Abstract

COPD and Hypertension:Does Inhalation Therapy Influence Blood Pressure Control?

Alina Babets

Poster

Abstract

Heart stress / heart failure in COPD: NT-proBNP and the impact of SITT

Pier-valerio Mari

Abstract

Evaluation of Disease Control and Quality of Life in Greek Asthma Patients With or Without Comorbidities Treated With Budesonide/Formoterol FDC: A Subgroup Analysis From the NOTOS Study

Maria Bertoli

Poster

Abstract

Protective role of salbutamol against aminophylline-induced arrhythmias in an hPSC-based cardiac model

Martin Scurek

Poster

Abstract

Inhaled pitavastatin reduces airway hyperresponsiveness and air trapping: implications for the treatment of asthma and COPD

Yuto Yasuda

Poster

Abstract

Impact of primary diagnosis of SA or CRSwNP on comorbid patients Baseline features in the RESPONSE study

Florence Schleich

Poster

Abstract

Costs of Multimorbidity in Asthma Patients in Singapore

Wenjia Chen

Poster

Abstract

Quinine use and the risk of exacerbations of chronic obstructive pulmonary disease: a nationwide retrospective registry study

Pradeesh Sivapalan

Poster

Abstract

Characterizing the burden of CRSwNP in the biologic era

Lucia De Prado Gomez

Poster

Abstract

Are adults with COPD in Australian primary care at a greater risk of cardiovascular events than adults without COPD?

Russell Wiseman

Poster

Abstract

Effectiveness of Benralizumab regarding comorbidities.

Angel Carmona Gonzalez

Poster

Abstract

Statins lower outpatient and hospitalised exacerbation risk beyond exacerbation history

Sam Beckx

Poster

Abstract

Carotid artery disease (CAD) as a comorbidity in COPD patients

Daniela Buklioska Ilievska

Poster

Abstract

Comparison of inhaled medications for cardiovascular events prevention after exacerbation of chronic obstructive pulmonary disease

Tsuyoshi Sasada

Poster

Abstract

Consideration of ILAs and Cardiovascular Risk in COPD

Hiro Ikeda

Poster

Abstract

Mental health comorbidity in patients undergoing assessment for severe asthma biologic therapy: identifying unmet clinical need.

Balamayran Ketheeswaran

Poster

Abstract

Association of Heart Rate Recovery (HRR) with Pulmonary Function Tests and Clinical Indicators in Patients with Stable COPD

Ayse Demirkaya

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}